{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,17]],"date-time":"2026-07-17T05:02:48Z","timestamp":1784264568640,"version":"3.55.0"},"reference-count":60,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2026,7,2]],"date-time":"2026-07-02T00:00:00Z","timestamp":1782950400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,7,2]],"date-time":"2026-07-02T00:00:00Z","timestamp":1782950400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"Scientific Research Fund Project of Yunnan Provincial Department of Education","award":["2024J1236"],"award-info":[{"award-number":["2024J1236"]}]},{"name":"Scientific Research Fund Project of Yunnan Provincial Department of Education","award":["2025J1258"],"award-info":[{"award-number":["2025J1258"]}]},{"name":"Yunnan Province College Students' Innovation and Entrepreneurship Training Program","award":["S202413332011"],"award-info":[{"award-number":["S202413332011"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Human Cell"],"DOI":"10.1007\/s13577-026-01403-2","type":"journal-article","created":{"date-parts":[[2026,7,2]],"date-time":"2026-07-02T11:33:17Z","timestamp":1782991997000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Bone marrow mesenchymal stem cell-derived exosomes exert therapeutic effects on inflammatory bowel disease through miR-148a-3p\/Ets-1-dependent inhibition of pyroptosis"],"prefix":"10.1007","volume":"39","author":[{"given":"Feilong","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ji","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yunjiao","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hejun","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ping","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caixiao","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meinan","family":"Zhan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Hou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiangli","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0009-5766-9825","authenticated-orcid":false,"given":"Wenjuan","family":"Shen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,2]]},"reference":[{"issue":"2","key":"1403_CR1","doi-asserted-by":"publisher","first-page":"444","DOI":"10.1016\/j.immuni.2023.01.002","volume":"56","author":"L Kong","year":"2023","unstructured":"Kong L, Pokatayev V, Lefkovith A, Carter GT, Creasey EA, Krishna C, et al. The landscape of immune dysregulation in Crohn\u2019s disease revealed through single-cell transcriptomic profiling in the ileum and colon. Immunity. 2023;56(2):444-458.e5. https:\/\/doi.org\/10.1016\/j.immuni.2023.01.002.","journal-title":"Immunity"},{"key":"1403_CR2","doi-asserted-by":"publisher","DOI":"10.3389\/fcimb.2021.755650","volume":"11","author":"L Qv","year":"2021","unstructured":"Qv L, Mao S, Li Y, Zhang J, Li L. Roles of gut bacteriophages in the pathogenesis and treatment of inflammatory bowel disease. Front Cell Infect Microbiol. 2021;11:755650. https:\/\/doi.org\/10.3389\/fcimb.2021.755650.","journal-title":"Front Cell Infect Microbiol"},{"issue":"1","key":"1403_CR3","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1038\/nrgastro.2017.136","volume":"15","author":"AN Ananthakrishnan","year":"2018","unstructured":"Ananthakrishnan AN, Bernstein CN, Iliopoulos D, Macpherson A, Neurath MF, Ali RAR, et al. Environmental triggers in IBD: a review of progress and evidence. Nat Rev Gastroenterol Hepatol. 2018;15(1):39\u201349. https:\/\/doi.org\/10.1038\/nrgastro.2017.136.","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"1403_CR4","doi-asserted-by":"publisher","DOI":"10.1016\/j.pharmthera.2022.108176","volume":"238","author":"X Pan","year":"2022","unstructured":"Pan X, Zhu Q, Pan LL, Sun J. Macrophage immunometabolism in inflammatory bowel diseases: From pathogenesis to therapy. Pharmacol Ther. 2022;238:108176. https:\/\/doi.org\/10.1016\/j.pharmthera.2022.108176.","journal-title":"Pharmacol Ther"},{"key":"1403_CR5","doi-asserted-by":"publisher","first-page":"1094","DOI":"10.3389\/fimmu.2019.01094","volume":"10","author":"R Garcia-Carbonell","year":"2019","unstructured":"Garcia-Carbonell R, Yao SJ, Das S, Guma M. Dysregulation of intestinal epithelial cell ripk pathways promotes chronic inflammation in the IBD gut. Front Immunol. 2019;10:1094. https:\/\/doi.org\/10.3389\/fimmu.2019.01094.","journal-title":"Front Immunol"},{"issue":"9","key":"1403_CR6","doi-asserted-by":"publisher","first-page":"821","DOI":"10.1080\/17474124.2017.1343143","volume":"11","author":"M Vancamelbeke","year":"2017","unstructured":"Vancamelbeke M, Vermeire S. The intestinal barrier: a fundamental role in health and disease. Expert Rev Gastroenterol Hepatol. 2017;11(9):821\u201334. https:\/\/doi.org\/10.1080\/17474124.2017.1343143.","journal-title":"Expert Rev Gastroenterol Hepatol"},{"issue":"2","key":"1403_CR7","doi-asserted-by":"publisher","DOI":"10.1080\/21688370.2018.1463897","volume":"6","author":"AN Anbazhagan","year":"2018","unstructured":"Anbazhagan AN, Priyamvada S, Alrefai WA, Dudeja PK. Pathophysiology of IBD associated diarrhea. Tissue Barriers. 2018;6(2):e1463897. https:\/\/doi.org\/10.1080\/21688370.2018.1463897.","journal-title":"Tissue Barriers"},{"issue":"3","key":"1403_CR8","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1016\/j.pop.2023.03.009","volume":"50","author":"LP Bruner","year":"2023","unstructured":"Bruner LP, White AM, Proksell S. Inflammatory bowel disease. Prim Care. 2023;50(3):411\u201327. https:\/\/doi.org\/10.1016\/j.pop.2023.03.009.","journal-title":"Prim Care"},{"issue":"1","key":"1403_CR9","doi-asserted-by":"publisher","first-page":"4428","DOI":"10.1038\/s41467-022-32158-7","volume":"13","author":"D Xu","year":"2022","unstructured":"Xu D, Ma R, Ju Y, Song X, Niu B, Hong W, et al. Cholesterol sulfate alleviates ulcerative colitis by promoting cholesterol biosynthesis in colonic epithelial cells. Nat Commun. 2022;13(1):4428. https:\/\/doi.org\/10.1038\/s41467-022-32158-7.","journal-title":"Nat Commun"},{"key":"1403_CR10","unstructured":"Hoilat GJ, Rentea RM, Crohn Disease Stricturoplasty, in StatPearls. 2025, StatPearls Publishing Copyright \u00a9 2025, StatPearls Publishing LLC.: Treasure Island (FL) ineligible companies. Disclosure: Rebecca Rentea declares no relevant financial relationships with ineligible companies."},{"issue":"6","key":"1403_CR11","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1053\/j.sempedsurg.2017.10.003","volume":"26","author":"YR Yu","year":"2017","unstructured":"Yu YR, Rodriguez JR. Clinical presentation of Crohn\u2019s, ulcerative colitis, and indeterminate colitis: symptoms, extraintestinal manifestations, and disease phenotypes. Semin Pediatr Surg. 2017;26(6):349\u201355. https:\/\/doi.org\/10.1053\/j.sempedsurg.2017.10.003.","journal-title":"Semin Pediatr Surg"},{"issue":"10114","key":"1403_CR12","doi-asserted-by":"publisher","first-page":"2769","DOI":"10.1016\/s0140-6736(17)32448-0","volume":"390","author":"SC Ng","year":"2017","unstructured":"Ng SC, Shi HY, Hamidi N, Underwood FE, Tang W, Benchimol EI, et al. Worldwide incidence and prevalence of inflammatory bowel disease in the 21st century: a systematic review of population-based studies. Lancet. 2017;390(10114):2769\u201378. https:\/\/doi.org\/10.1016\/s0140-6736(17)32448-0.","journal-title":"Lancet"},{"issue":"4","key":"1403_CR13","doi-asserted-by":"publisher","first-page":"617","DOI":"10.1038\/ajg.2011.71","volume":"106","author":"AC Ford","year":"2011","unstructured":"Ford AC, Kane SV, Khan KJ, Achkar JP, Talley NJ, Marshall JK, et al. Efficacy of 5-aminosalicylates in Crohn\u2019s disease: systematic review and meta-analysis. Am J Gastroenterol. 2011;106(4):617\u201329. https:\/\/doi.org\/10.1038\/ajg.2011.71.","journal-title":"Am J Gastroenterol"},{"issue":"9","key":"1403_CR14","doi-asserted-by":"publisher","first-page":"716","DOI":"10.1016\/j.gastrohep.2022.10.017","volume":"46","author":"R Quera","year":"2023","unstructured":"Quera R, N\u00fa\u00f1ez P, Sicilia B, Flores L, Gomoll\u00f3n F. Corticosteroids in inflammatory bowel disease: are they still a therapeutic option? Gastroenterol Hepatol. 2023;46(9):716\u201326. https:\/\/doi.org\/10.1016\/j.gastrohep.2022.10.017.","journal-title":"Gastroenterol Hepatol"},{"issue":"4","key":"1403_CR15","doi-asserted-by":"publisher","first-page":"455","DOI":"10.5009\/gnl16308","volume":"11","author":"KH Katsanos","year":"2017","unstructured":"Katsanos KH, Papadakis KA. Inflammatory bowel disease: updates on molecular targets for biologics. Gut Liver. 2017;11(4):455\u201363. https:\/\/doi.org\/10.5009\/gnl16308.","journal-title":"Gut Liver"},{"issue":"4","key":"1403_CR16","doi-asserted-by":"publisher","first-page":"487","DOI":"10.5217\/ir.2017.15.4.487","volume":"15","author":"WC Lin","year":"2017","unstructured":"Lin WC, Chou JW, Yen HH, Hsu WH, Lin HH, Lin JK, et al. Outcomes of limited period of adalimumab treatment in moderate to severe Crohn\u2019s disease patients: Taiwan society of inflammatory bowel disease study. Intest Res. 2017;15(4):487\u201394. https:\/\/doi.org\/10.5217\/ir.2017.15.4.487.","journal-title":"Intest Res"},{"issue":"9","key":"1403_CR17","doi-asserted-by":"publisher","first-page":"2768","DOI":"10.1016\/j.apsb.2021.02.006","volume":"11","author":"BE Burdette","year":"2021","unstructured":"Burdette BE, Esparza AN, Zhu H, Wang S. Gasdermin D in pyroptosis. Acta Pharm Sin B. 2021;11(9):2768\u201382. https:\/\/doi.org\/10.1016\/j.apsb.2021.02.006.","journal-title":"Acta Pharm Sin B"},{"issue":"2","key":"1403_CR18","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1016\/j.cell.2021.12.024","volume":"185","author":"N Rana","year":"2022","unstructured":"Rana N, Privitera G, Kondolf HC, Bulek K, Lechuga S, De Salvo C, et al. GSDMB is increased in IBD and regulates epithelial restitution\/repair independent of pyroptosis. Cell. 2022;185(2):283-298.e17. https:\/\/doi.org\/10.1016\/j.cell.2021.12.024.","journal-title":"Cell"},{"key":"1403_CR19","doi-asserted-by":"publisher","first-page":"276","DOI":"10.3389\/fimmu.2019.00276","volume":"10","author":"Y Zhen","year":"2019","unstructured":"Zhen Y, Zhang H. NLRP3 Inflammasome and inflammatory bowel disease. Front Immunol. 2019;10:276. https:\/\/doi.org\/10.3389\/fimmu.2019.00276.","journal-title":"Front Immunol"},{"issue":"26","key":"1403_CR20","doi-asserted-by":"publisher","first-page":"16658","DOI":"10.1021\/acsnano.4c01520","volume":"18","author":"W Li","year":"2024","unstructured":"Li W, Chen D, Zhu Y, Ye Q, Hua Y, Jiang P, et al. Alleviating pyroptosis of intestinal epithelial cells to restore mucosal integrity in ulcerative colitis by targeting delivery of 4-Octyl-Itaconate. ACS Nano. 2024;18(26):16658\u201373. https:\/\/doi.org\/10.1021\/acsnano.4c01520.","journal-title":"ACS Nano"},{"issue":"1","key":"1403_CR21","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1186\/s40001-023-01008-7","volume":"28","author":"MJ Saadh","year":"2023","unstructured":"Saadh MJ, Mikhailova MV, Rasoolzadegan S, Falaki M, Akhavanfar R, Gonz\u00e1les JLA, et al. Therapeutic potential of mesenchymal stem\/stromal cells (MSCs)-based cell therapy for inflammatory bowel diseases (IBD) therapy. Eur J Med Res. 2023;28(1):47. https:\/\/doi.org\/10.1186\/s40001-023-01008-7.","journal-title":"Eur J Med Res"},{"issue":"6","key":"1403_CR22","doi-asserted-by":"publisher","first-page":"664","DOI":"10.5009\/gnl18072","volume":"12","author":"H Jo","year":"2018","unstructured":"Jo H, Eom YW, Kim HS, Park HJ, Kim HM, Cho MY. Regulatory dendritic cells induced by mesenchymal stem cells ameliorate dextran sodium sulfate-induced chronic colitis in mice. Gut Liver. 2018;12(6):664\u201373. https:\/\/doi.org\/10.5009\/gnl18072.","journal-title":"Gut Liver"},{"issue":"3","key":"1403_CR23","doi-asserted-by":"publisher","DOI":"10.1016\/j.semperi.2023.151727","volume":"47","author":"FM Mesfin","year":"2023","unstructured":"Mesfin FM, Manohar K, Hunter CE, Shelley WC, Brokaw JP, Liu J, et al. Stem cell derived therapies to preserve and repair the developing intestine. Semin Perinatol. 2023;47(3):151727. https:\/\/doi.org\/10.1016\/j.semperi.2023.151727.","journal-title":"Semin Perinatol"},{"key":"1403_CR24","doi-asserted-by":"publisher","DOI":"10.3389\/fcell.2021.705676","volume":"9","author":"J Johnson","year":"2021","unstructured":"Johnson J, Shojaee M, Mitchell Crow J, Khanabdali R. From mesenchymal stromal cells to engineered extracellular vesicles: a new therapeutic paradigm. Front Cell Dev Biol. 2021;9:705676. https:\/\/doi.org\/10.3389\/fcell.2021.705676.","journal-title":"Front Cell Dev Biol"},{"key":"1403_CR25","doi-asserted-by":"publisher","DOI":"10.1016\/j.intimp.2025.115136","volume":"162","author":"X Peng","year":"2025","unstructured":"Peng X, Cui H, Tan S, Wen B, Luo X, Chen S, et al. The engineered bone marrow mesenchymal stem cell-derived exosome: A new strategy for the treatment of inflammatory diseases. Int Immunopharmacol. 2025;162:115136. https:\/\/doi.org\/10.1016\/j.intimp.2025.115136.","journal-title":"Int Immunopharmacol"},{"key":"1403_CR26","doi-asserted-by":"publisher","first-page":"10857","DOI":"10.2147\/ijn.S527137","volume":"20","author":"J Zhang","year":"2025","unstructured":"Zhang J, Tian X, Li Y, Fang C, Yang F, Dong L, et al. Stem cell-derived exosomes: a comprehensive review of biomedical applications, challenges, and future directions. Int J Nanomed. 2025;20:10857\u2013905. https:\/\/doi.org\/10.2147\/ijn.S527137.","journal-title":"Int J Nanomed"},{"key":"1403_CR27","doi-asserted-by":"publisher","DOI":"10.3390\/ijms23126480","author":"Y Matsuzaka","year":"2022","unstructured":"Matsuzaka Y, Yashiro R. Therapeutic strategy of mesenchymal-stem-cell-derived extracellular vesicles as regenerative medicine. Int J Mol Sci. 2022. https:\/\/doi.org\/10.3390\/ijms23126480.","journal-title":"Int J Mol Sci"},{"key":"1403_CR28","doi-asserted-by":"publisher","DOI":"10.3389\/fmolb.2022.854487","volume":"9","author":"EJ Park","year":"2022","unstructured":"Park EJ, Shimaoka M, Kiyono H. Functional flexibility of exosomes and MicroRNAs of intestinal epithelial cells in affecting inflammation. Front Mol Biosci. 2022;9:854487. https:\/\/doi.org\/10.3389\/fmolb.2022.854487.","journal-title":"Front Mol Biosci"},{"issue":"3","key":"1403_CR29","doi-asserted-by":"publisher","first-page":"440","DOI":"10.15283\/ijsc18139","volume":"12","author":"ZJ Ma","year":"2019","unstructured":"Ma ZJ, Wang YH, Li ZG, Wang Y, Li BY, Kang HY, et al. Immunosuppressive effect of exosomes from mesenchymal stromal cells in defined medium on experimental colitis. Int J Stem Cells. 2019;12(3):440\u20138. https:\/\/doi.org\/10.15283\/ijsc18139.","journal-title":"Int J Stem Cells"},{"issue":"1","key":"1403_CR30","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/j.gpb.2015.02.001","volume":"13","author":"J Zhang","year":"2015","unstructured":"Zhang J, Li S, Li L, Li M, Guo C, Yao J, et al. Exosome and exosomal microRNA: trafficking, sorting, and function. Genomics Proteomics Bioinf. 2015;13(1):17\u201324. https:\/\/doi.org\/10.1016\/j.gpb.2015.02.001.","journal-title":"Genomics Proteomics Bioinf"},{"issue":"1","key":"1403_CR31","doi-asserted-by":"publisher","first-page":"62","DOI":"10.18388\/pb.2021_515","volume":"70","author":"V Ambros","year":"2024","unstructured":"Ambros V. MicroRNA-mediated gene regulation and the resilience of multicellular animals. Postepy Biochem. 2024;70(1):62\u201370. https:\/\/doi.org\/10.18388\/pb.2021_515.","journal-title":"Postepy Biochem"},{"issue":"1","key":"1403_CR32","doi-asserted-by":"publisher","first-page":"188","DOI":"10.1186\/s12951-023-01951-x","volume":"21","author":"Z Wei","year":"2023","unstructured":"Wei Z, Hang S, Wiredu Ocansey DK, Zhang Z, Wang B, Zhang X, et al. Human umbilical cord mesenchymal stem cells derived exosome shuttling mir-129-5p attenuates inflammatory bowel disease by inhibiting ferroptosis. J Nanobiotechnol. 2023;21(1):188. https:\/\/doi.org\/10.1186\/s12951-023-01951-x.","journal-title":"J Nanobiotechnol"},{"issue":"2","key":"1403_CR33","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1089\/dna.2023.0341","volume":"43","author":"S Dong","year":"2024","unstructured":"Dong S, Xu G, Li X, Guo S, Bai J, Zhao J, et al. Exosomes derived from quercetin-treated bone marrow derived mesenchymal stem cells inhibit the progression of osteoarthritis through delivering miR-124-3p to chondrocytes. DNA Cell Biol. 2024;43(2):85\u201394. https:\/\/doi.org\/10.1089\/dna.2023.0341.","journal-title":"DNA Cell Biol"},{"key":"1403_CR34","doi-asserted-by":"publisher","DOI":"10.1016\/j.lfs.2020.118218","volume":"259","author":"Z Bolandi","year":"2020","unstructured":"Bolandi Z, Mokhberian N, Eftekhary M, Sharifi K, Soudi S, Ghanbarian H, et al. Adipose derived mesenchymal stem cell exosomes loaded with miR-10a promote the differentiation of Th17 and Treg from naive CD4(+) T cell. Life Sci. 2020;259:118218. https:\/\/doi.org\/10.1016\/j.lfs.2020.118218.","journal-title":"Life Sci"},{"issue":"2","key":"1403_CR35","doi-asserted-by":"publisher","first-page":"191","DOI":"10.4252\/wjsc.v16.i2.191","volume":"16","author":"F Yang","year":"2024","unstructured":"Yang F, Xiong WQ, Li CZ, Wu MJ, Zhang XZ, Ran CX, et al. Extracellular vesicles derived from mesenchymal stem cells mediate extracellular matrix remodeling in osteoarthritis through the transport of microRNA-29a. World J Stem Cells. 2024;16(2):191\u2013206. https:\/\/doi.org\/10.4252\/wjsc.v16.i2.191.","journal-title":"World J Stem Cells"},{"key":"1403_CR36","doi-asserted-by":"publisher","DOI":"10.1016\/j.abb.2020.108712","volume":"697","author":"Y Wu","year":"2021","unstructured":"Wu Y, Li J, Yuan R, Deng Z, Wu X. Bone marrow mesenchymal stem cell-derived exosomes alleviate hyperoxia-induced lung injury via the manipulation of microRNA-425. Arch Biochem Biophys. 2021;697:108712. https:\/\/doi.org\/10.1016\/j.abb.2020.108712.","journal-title":"Arch Biochem Biophys"},{"issue":"45","key":"1403_CR37","doi-asserted-by":"publisher","DOI":"10.1002\/smll.202507073","volume":"21","author":"X Li","year":"2025","unstructured":"Li X, Li X, Hu J, Zhu Y, Pang Z, Chen M, et al. Spheroid-derived bmsc exosomes enhance proliferation and matrix remodeling of nucleus pulposus cell clusters in degenerative disc repair. Small. 2025;21(45):e07073. https:\/\/doi.org\/10.1002\/smll.202507073.","journal-title":"Small"},{"key":"1403_CR38","doi-asserted-by":"publisher","DOI":"10.3390\/ijms25105087","author":"C Anastasio","year":"2024","unstructured":"Anastasio C, Donisi I, Colloca A, D\u2019Onofrio N, Balestrieri ML. MiR-148a-3p\/SIRT7 Axis relieves inflammatory-induced endothelial dysfunction. Int J Mol Sci. 2024. https:\/\/doi.org\/10.3390\/ijms25105087.","journal-title":"Int J Mol Sci"},{"issue":"22","key":"1403_CR39","doi-asserted-by":"publisher","first-page":"1201","DOI":"10.21037\/atm-22-3768","volume":"10","author":"K Wang","year":"2022","unstructured":"Wang K, Huang XT, Miao YP, Bai XL, Jin F. MiR-148a-3p attenuates apoptosis and inflammation by targeting CNTN4 in atherosclerosis. Ann Transl Med. 2022;10(22):1201. https:\/\/doi.org\/10.21037\/atm-22-3768.","journal-title":"Ann Transl Med"},{"issue":"5","key":"1403_CR40","doi-asserted-by":"publisher","first-page":"12927","DOI":"10.1080\/21655979.2022.2079242","volume":"13","author":"C Juan","year":"2022","unstructured":"Juan C, Zhu Y, Chen Y, Mao Y, Zhou Y, Zhu W, et al. Knocking down ETS Proto-oncogene 1 (ETS1) alleviates the pyroptosis of renal tubular epithelial cells in patients with acute kidney injury by regulating the NLR family pyrin domain containing 3 (NLRP3) transcription. Bioengineered. 2022;13(5):12927\u201340. https:\/\/doi.org\/10.1080\/21655979.2022.2079242.","journal-title":"Bioengineered"},{"key":"1403_CR41","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaut.2022.102872","volume":"132","author":"Q He","year":"2022","unstructured":"He Q, Gao H, Chang YL, Wu X, Lin R, Li G, et al. ETS-1 facilitates Th1 cell-mediated mucosal inflammation in inflammatory bowel diseases through upregulating CIRBP. J Autoimmun. 2022;132:102872. https:\/\/doi.org\/10.1016\/j.jaut.2022.102872.","journal-title":"J Autoimmun"},{"issue":"8","key":"1403_CR42","doi-asserted-by":"publisher","first-page":"5906","DOI":"10.1002\/jcp.30275","volume":"236","author":"N Heidari","year":"2021","unstructured":"Heidari N, Abbasi-Kenarsari H, Namaki S, Baghaei K, Zali MR, Ghaffari Khaligh S, et al. Adipose-derived mesenchymal stem cell-secreted exosome alleviates dextran sulfate sodium-induced acute colitis by Treg cell induction and inflammatory cytokine reduction. J Cell Physiol. 2021;236(8):5906\u201320. https:\/\/doi.org\/10.1002\/jcp.30275.","journal-title":"J Cell Physiol"},{"issue":"3","key":"1403_CR43","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1097\/MIB.0b013e31828028e8","volume":"19","author":"E Franz\u00e8","year":"2013","unstructured":"Franz\u00e8 E, Caruso R, Stolfi C, Sarra M, Cupi ML, Ascolani M, et al. High expression of the \u201cA Disintegrin And Metalloprotease\u201d 19 (ADAM19), a sheddase for TNF-\u03b1 in the mucosa of patients with inflammatory bowel diseases. Inflamm Bowel Dis. 2013;19(3):501\u201311. https:\/\/doi.org\/10.1097\/MIB.0b013e31828028e8.","journal-title":"Inflamm Bowel Dis"},{"issue":"4","key":"1403_CR44","doi-asserted-by":"publisher","first-page":"655","DOI":"10.1016\/j.gtc.2020.07.001","volume":"49","author":"T Kaenkumchorn","year":"2020","unstructured":"Kaenkumchorn T, Wahbeh G. Ulcerative colitis: making the diagnosis. Gastroenterol Clin North Am. 2020;49(4):655\u201369. https:\/\/doi.org\/10.1016\/j.gtc.2020.07.001.","journal-title":"Gastroenterol Clin North Am"},{"issue":"13","key":"1403_CR45","doi-asserted-by":"publisher","first-page":"1215","DOI":"10.1056\/NEJMoa1905725","volume":"381","author":"BE Sands","year":"2019","unstructured":"Sands BE, Peyrin-Biroulet L, Loftus EV Jr, Danese S, Colombel JF, T\u00f6r\u00fcner M, et al. Vedolizumab versus adalimumab for moderate-to-severe ulcerative colitis. N Engl J Med. 2019;381(13):1215\u201326. https:\/\/doi.org\/10.1056\/NEJMoa1905725.","journal-title":"N Engl J Med"},{"key":"1403_CR46","doi-asserted-by":"publisher","DOI":"10.1016\/j.intimp.2022.109545","volume":"114","author":"C Dai","year":"2023","unstructured":"Dai C, Huang YH, Jiang M. Combination therapy in inflammatory bowel disease: current evidence and perspectives. Int Immunopharmacol. 2023;114:109545. https:\/\/doi.org\/10.1016\/j.intimp.2022.109545.","journal-title":"Int Immunopharmacol"},{"issue":"9","key":"1403_CR47","doi-asserted-by":"publisher","first-page":"1324","DOI":"10.1038\/ajg.2015.233","volume":"110","author":"L Peyrin-Biroulet","year":"2015","unstructured":"Peyrin-Biroulet L, Sandborn W, Sands BE, Reinisch W, Bemelman W, Bryant RV, et al. Selecting therapeutic targets in inflammatory bowel disease (stride): determining therapeutic goals for treat-to-target. Am J Gastroenterol. 2015;110(9):1324\u201338. https:\/\/doi.org\/10.1038\/ajg.2015.233.","journal-title":"Am J Gastroenterol"},{"issue":"4","key":"1403_CR48","doi-asserted-by":"publisher","first-page":"851","DOI":"10.1002\/stem.2575","volume":"35","author":"DG Phinney","year":"2017","unstructured":"Phinney DG, Pittenger MF. Concise review: msc-derived exosomes for cell-free therapy. Stem Cells. 2017;35(4):851\u20138. https:\/\/doi.org\/10.1002\/stem.2575.","journal-title":"Stem Cells"},{"issue":"1","key":"1403_CR49","doi-asserted-by":"publisher","DOI":"10.1016\/j.yexcr.2022.113296","volume":"419","author":"N Heidari","year":"2022","unstructured":"Heidari N, Abbasi-Kenarsari H, Namaki S, Baghaei K, Zali MR, Mirsanei Z, et al. Regulation of the Th17\/Treg balance by human umbilical cord mesenchymal stem cell-derived exosomes protects against acute experimental colitis. Exp Cell Res. 2022;419(1):113296. https:\/\/doi.org\/10.1016\/j.yexcr.2022.113296.","journal-title":"Exp Cell Res"},{"key":"1403_CR50","doi-asserted-by":"publisher","DOI":"10.1016\/j.lfs.2025.123499","volume":"368","author":"OM Saka","year":"2025","unstructured":"Saka OM, Dora DD, Kibar G, Tevlek A. Expanding the role of exosomes in drug, biomolecule, and nanoparticle delivery. Life Sci. 2025;368:123499. https:\/\/doi.org\/10.1016\/j.lfs.2025.123499.","journal-title":"Life Sci"},{"issue":"11","key":"1403_CR51","first-page":"7020","volume":"12","author":"W Chen","year":"2020","unstructured":"Chen W, Wang X, Yan X, Yu Z, Zhang J, Han S. The emerging role of exosomes in the pathogenesis, prognosis and treatment of necrotizing enterocolitis. Am J Transl Res. 2020;12(11):7020\u201333.","journal-title":"Am J Transl Res"},{"key":"1403_CR52","doi-asserted-by":"publisher","DOI":"10.3390\/ijms17122028","author":"X Yu","year":"2016","unstructured":"Yu X, Odenthal M, Fries JW. Exosomes as miRNA carriers: formation-function-future. Int J Mol Sci. 2016. https:\/\/doi.org\/10.3390\/ijms17122028.","journal-title":"Int J Mol Sci"},{"issue":"1","key":"1403_CR53","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1016\/j.cell.2018.03.006","volume":"173","author":"DP Bartel","year":"2018","unstructured":"Bartel DP. Metazoan MicroRNAs. Cell. 2018;173(1):20\u201351. https:\/\/doi.org\/10.1016\/j.cell.2018.03.006.","journal-title":"Cell"},{"issue":"4","key":"1403_CR54","doi-asserted-by":"publisher","first-page":"2235","DOI":"10.1021\/acsbiomaterials.3c01567","volume":"10","author":"Q Zhang","year":"2024","unstructured":"Zhang Q, Su P, Zhao F, Ren H, He C, Wu Q, et al. Enhancing skin injury repair: combined application of PF-127 hydrogel and hADSC-Exos containing miR-148a-3p. ACS Biomater Sci Eng. 2024;10(4):2235\u201350. https:\/\/doi.org\/10.1021\/acsbiomaterials.3c01567.","journal-title":"ACS Biomater Sci Eng"},{"key":"1403_CR55","doi-asserted-by":"publisher","DOI":"10.1016\/j.intimp.2023.110440","volume":"121","author":"Y Zhong","year":"2023","unstructured":"Zhong Y, Wang S, Yin Y, Yu J, Liu Y, Gao H. Dexmedetomidine suppresses hippocampal astrocyte pyroptosis in cerebral hypoxic-ischemic neonatal rats by upregulating microRNA-148a-3p to inactivate the STAT\/JMJD3 axis. Int Immunopharmacol. 2023;121:110440. https:\/\/doi.org\/10.1016\/j.intimp.2023.110440.","journal-title":"Int Immunopharmacol"},{"issue":"7","key":"1403_CR56","doi-asserted-by":"publisher","first-page":"1487","DOI":"10.1002\/cbin.11588","volume":"45","author":"C Tan","year":"2021","unstructured":"Tan C, Liu W, Zheng ZH, Wan XG. LncRNA HOTTIP inhibits cell pyroptosis by targeting miR-148a-3p\/AKT2 axis in ovarian cancer. Cell Biol Int. 2021;45(7):1487\u201397. https:\/\/doi.org\/10.1002\/cbin.11588.","journal-title":"Cell Biol Int"},{"issue":"6","key":"1403_CR57","first-page":"495","volume":"41","author":"W Yan","year":"2025","unstructured":"Yan W, Han B, Lin L, Chen L, Qu J, Li X. Study on the promotion of podocyte pyroptosis by high glucose-stimulated GMC-derived exosomes and the intervention effects of Tongluo Yishen Formula. Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi. 2025;41(6):495\u2013504.","journal-title":"Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi"},{"key":"1403_CR58","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1016\/j.jaut.2019.04.014","volume":"101","author":"Y Ge","year":"2019","unstructured":"Ge Y, Sun M, Wu W, Ma C, Zhang C, He C, et al. MicroRNA-125a suppresses intestinal mucosal inflammation through targeting ETS-1 in patients with inflammatory bowel diseases. J Autoimmun. 2019;101:109\u201320. https:\/\/doi.org\/10.1016\/j.jaut.2019.04.014.","journal-title":"J Autoimmun"},{"key":"1403_CR59","doi-asserted-by":"publisher","first-page":"1526368","DOI":"10.3389\/fimmu.2025.1526368","volume":"16","author":"S Wang","year":"2025","unstructured":"Wang S, Wan L, Zhang X, Fang H, Zhang M, Li F, et al. ETS-1 in tumor immunology: implications for novel anti-cancer strategies. Front Immunol. 2025;16:1526368. https:\/\/doi.org\/10.3389\/fimmu.2025.1526368.","journal-title":"Front Immunol"},{"issue":"8","key":"1403_CR60","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1016\/j.autrev.2011.01.007","volume":"10","author":"RX Leng","year":"2011","unstructured":"Leng RX, Pan HF, Chen GM, Feng CC, Fan YG, Ye DQ, et al. The dual nature of Ets-1: focus to the pathogenesis of systemic lupus erythematosus. Autoimmun Rev. 2011;10(8):439\u201343. https:\/\/doi.org\/10.1016\/j.autrev.2011.01.007.","journal-title":"Autoimmun Rev"}],"container-title":["Human Cell"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13577-026-01403-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s13577-026-01403-2","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13577-026-01403-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,2]],"date-time":"2026-07-02T11:33:26Z","timestamp":1782992006000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s13577-026-01403-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,2]]},"references-count":60,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2026,7]]}},"alternative-id":["1403"],"URL":"https:\/\/doi.org\/10.1007\/s13577-026-01403-2","relation":{},"ISSN":["1749-0774"],"issn-type":[{"value":"1749-0774","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,2]]},"assertion":[{"value":"4 December 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 June 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 July 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"This study was reviewed and approved by the Ethics Committee of Kunming Medical University Haiyuan College. All experimental procedures involving animals were designed to minimize suffering, and the animal care and use protocols were in line with the ethical standards of Kunming Medical University Haiyuan College (Ethics approval No.: HYXY2025X0013).","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}}],"article-number":"97"}}